ArticleContemporary oncology (Poznan, Poland)2025

First report of refractory grey zone lymphoma in an adolescent patient treated successfully with pembrolizumab.

Maria Dudzik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.